COVID19 infection in diabetic patients

Forms of COVID19 range from a mild cold to multi-systemic failure. Several factors come into play, including the background. Study the clinical, and progressive characteristics of COVId19 infection in diabetic patients and to assess morbidity associated factors. Materials and methods: Case control study including 200 patients hospitalized for COVID 19infectio n distributed as follows: 100 diabetic patients and 100 non-diabetic patients. There Patients with multiple histories were more at risk of having severe forms and belonged to G1. Hypoxemia was more severe in G1 (p=0.01). Hyperleukocytosis and lymphopenia were more common in G1 (p<0.001). CRP and DDimer levels were also higher in this group (p<0.001). Diabetics had higher urea figures (p<0.001). The chest CT scan showed that G1 had significantly more parenchymal ground glass lesions (87%, p=0.001), and pulmonary embolism (28%, p=0.001). Lesions were more extensive in G1. Fibrosis was more frequent in the same group: reticulation (p=0.0017), architectural distortion (p=0.019), and bronchiectasis (p=0.006). As for the evolution, G1 patients were at greater risk of death (p=0.03). Diabetes increases serious forms of COVID19, due to frequent comorbidities, and to diabetes itself with a significant inflammatory storm, and hypercoagulability, with specific complications of this endocrinopathy.